Form 8-K - Current report:
SEC Accession No. 0001654954-21-000995
Filing Date
2021-02-01
Accepted
2021-02-01 08:30:19
Documents
14
Period of Report
2021-02-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg-20211231.htm   iXBRL 8-K 185791
  Complete submission text file 0001654954-21-000995.txt   326451

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbmg-20211231.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbmg-20211231_cal.xml EX-101.CAL 887
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbmg-20211231_def.xml EX-101.DEF 1886
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbmg-20211231_lab.xml EX-101.LAB 15875
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbmg-20211231_pre.xml EX-101.PRE 11623
7 EXTRACTED XBRL INSTANCE DOCUMENT cbmg-20211231_htm.xml XML 4327
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 21574774
SIC: 2836 Biological Products, (No Diagnostic Substances)